Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Healthy Returns
Recent news which mentions Healthy Returns
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
Tags
Health & Science
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Health care industry
Novartis AG
Johnson & Johnson
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Augmedix Inc
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Novo Nordisk A/S
Merck & Co Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
CVS Health Corp
UnitedHealth Group Inc
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Health & Science
Altimmune Inc
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health & Science
Labor economy
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags
Biotech and Pharmaceuticals
Pfizer Inc
Health & Science
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Merck & Co Inc
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags
Healthy Returns
Johnson & Johnson
Science
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Healthy Returns
Science
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Abbvie Inc
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
April 23, 2024
Tags
Biotech and Pharmaceuticals
Alto Neuroscience Inc
Health care industry
From
CNBC.com News
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
April 16, 2024
Tags
Healthy Returns
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Healthy Returns
Johnson & Johnson
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
AstraZeneca PLC
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Healthy Returns
Health care industry
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Madrigal Pharmaceuticals Inc
Akero Therapeutics Inc
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
Tags
Merck & Co Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: What to know about CDC’s new Covid recommendations
March 06, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Health & Science
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Biogen Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: Higher medical costs are pinching insurers
February 13, 2024
Tags
Social issues
Health & Science
Labor economy
From
CNBC.com News
Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes
February 06, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Bristol/Myers Squibb Co
Health & Science
Merck & Co Inc
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.